The Big Bad Wolf (aka the pharmaceutical companies) v the Competition Authorities: the economics of "pay-for-delay" settlements | Practical Law
This article considers recent decisions by the US Supreme Court and the European Commission relating to “reverse-payment” settlements in the pharmaceutical industry.